Jubilant Pharmova LimitedShare price targets & analyst calls
₹924.5+16.60 (+1.83%)
As of 4 Sept 2026
Analysts lean BUY·all 3 long-term calls are BUY·consensus 1Y target ₹1,427.33 (54.4% above CMP)
₹1,427.33
54.4% above CMP
₹1,310 – ₹1,557
3 active 1Y targets
3 open
3 BUY · 0 SELL (all horizons)
N/A
4 of 10 closed calls needed
Watch JUBLPHARMA for new buy/sell callsGet alertsSee 52 Pharmaceuticals & Biotechnology sector analyst picks
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
All tips (7) · loading…
BUYJUBLPHARMAJubilant PharmovaHorizon: 1 Year* (horizon not stated by the source; assumed from the target's distance) · 5 mo left
AI2+·6−-1.4% P&L+41.7% upside left
₹924.5
CMP
Entry*
₹937.65
Target
₹1,310
ISICICI Securities· via Institutional / Brokerage Research30w ago
BUYJUBLPHARMAJubilant PharmovaHorizon: 1 Year* (horizon not stated by the source; assumed from the target's distance) · 4 mo left
AI2+·6−-13.3% P&L+68.4% upside left
₹924.5
CMP
Entry*
₹1,066.3
Target
₹1,557
VVentura· via Institutional / Brokerage Research33w ago
BUYJUBLPHARMAJubilant PharmovaHorizon: 1 Year* (horizon not stated by the source; assumed from the target's distance) · 2 mo left
AI2+·6−-21.7% P&L+53.1% upside left
₹924.5
CMP
Entry*
₹1,181.2
Target
₹1,415
ISICICI Securities· via Institutional / Brokerage Research43w ago
BUYJUBLPHARMAJubilant PharmovaHorizon: 1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI1+·0−-7.02% realisedNA upside left
SL
₹960
Entry*
₹1,032.45
Target
₹1,120
hit 24 Jul 2026, 9:15 am
MKMehul Kothari, Anand Rathi· via Zee Business (Live)7w ago
BUYJUBLPHARMAJubilant PharmovaHorizon: 1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI1+·0−-3.71% realisedNA upside left
SL
₹980
Entry*
₹1,017.75
Target
₹1,065
hit 22 Jul 2026, 9:35 am
ABAshish Bahety, Profitmart Securities· via CNBC Awaaz.7w ago
BUYJUBLPHARMAJubilant PharmovaHorizon: 1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
-3.66% realisedNA upside left
SL
₹975
Entry
₹1,012
Target
₹1,075
hit 25 May 2026, 9:20 am
GSGaurav Sharma· via CNBC Awaaz.16w ago
BUYJUBLPHARMAJubilant PharmovaHorizon: 1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Expired
AI1+·1−-5.29% realisedNA upside left
₹930
At expiry
Entry*
₹981.9
Target
₹1,010
expired 7 Aug 2026, 3:30 pm
RSRajesh Satpute· via CNBC Awaaz.5w ago